IL90462A - Controlled release dosage forms having a defined water content - Google Patents
Controlled release dosage forms having a defined water contentInfo
- Publication number
- IL90462A IL90462A IL90462A IL9046289A IL90462A IL 90462 A IL90462 A IL 90462A IL 90462 A IL90462 A IL 90462A IL 9046289 A IL9046289 A IL 9046289A IL 90462 A IL90462 A IL 90462A
- Authority
- IL
- Israel
- Prior art keywords
- controlled release
- water content
- dosage forms
- release dosage
- defined water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888813064A GB8813064D0 (en) | 1988-06-02 | 1988-06-02 | Controlled release dosage forms having defined water content |
Publications (2)
Publication Number | Publication Date |
---|---|
IL90462A0 IL90462A0 (en) | 1990-01-18 |
IL90462A true IL90462A (en) | 1993-01-31 |
Family
ID=10637952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL90462A IL90462A (en) | 1988-06-02 | 1989-05-30 | Controlled release dosage forms having a defined water content |
Country Status (19)
Country | Link |
---|---|
US (1) | US5091189A (da) |
EP (1) | EP0344960B1 (da) |
JP (1) | JPH0816060B2 (da) |
KR (1) | KR0136279B1 (da) |
AT (1) | ATE83925T1 (da) |
AU (1) | AU610401B2 (da) |
CA (1) | CA1323834C (da) |
DE (1) | DE68904119T2 (da) |
DK (1) | DK175130B1 (da) |
ES (1) | ES2053989T3 (da) |
FI (1) | FI93695C (da) |
GB (2) | GB8813064D0 (da) |
GR (1) | GR3007088T3 (da) |
IE (1) | IE61998B1 (da) |
IL (1) | IL90462A (da) |
NO (1) | NO176232C (da) |
NZ (1) | NZ229372A (da) |
PT (1) | PT90722B (da) |
ZA (1) | ZA894201B (da) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6262115B1 (en) * | 1995-05-22 | 2001-07-17 | Alza Coporation | Method for the management of incontinence |
US5912268A (en) * | 1995-05-22 | 1999-06-15 | Alza Corporation | Dosage form and method for treating incontinence |
ES2264226T3 (es) * | 1997-12-22 | 2006-12-16 | Euro-Celtique S.A. | Forma farmaceutica de dosificacion oral que comprende una combinacion de un agonista opioide y naltrexona. |
YU39500A (sh) * | 1997-12-22 | 2003-02-28 | Euro-Celtique S.A. | Postupak sprečavanja zloupotrebe oblika za doziranje opijata |
EP1133230A4 (en) | 1998-11-23 | 2004-05-26 | Bonnie M Davis | DOSAGE FORMULAS FOR ACETYLCHOLINESTERASE INHIBITORS |
PT1255547E (pt) | 2000-02-08 | 2008-11-24 | Euro Celtique Sa | Composições de libertação controlada contendo agonistas e antagonistas opióides |
WO2002092060A1 (en) | 2001-05-11 | 2002-11-21 | Endo Pharmaceuticals, Inc. | Abuse-resistant controlled-release opioid dosage form |
US7052706B2 (en) * | 2001-06-08 | 2006-05-30 | Nostrum Pharmaceuticals, Inc. | Control release formulation containing a hydrophobic material as the sustained release agent |
PT1416842E (pt) * | 2001-07-18 | 2009-03-31 | Euro Celtique Sa | Composições farmacêuticas de oxicodona e naloxona |
US20030157168A1 (en) * | 2001-08-06 | 2003-08-21 | Christopher Breder | Sequestered antagonist formulations |
NZ530971A (en) | 2001-08-06 | 2004-08-27 | Euro Celtique S | Oral dosage forms comprising an opioid agonist with releasable and sequestered opioid antagonists |
US20030044458A1 (en) | 2001-08-06 | 2003-03-06 | Curtis Wright | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
IN192180B (da) * | 2001-09-28 | 2004-03-06 | Ranbaxy Lab | |
PT1485078E (pt) * | 2002-03-15 | 2013-01-14 | Cypress Bioscience Inc | Milnacipran para o tratamento do síndrome do intestino irritável |
US20050245556A1 (en) | 2002-04-05 | 2005-11-03 | Bianca Brogmann | Pharmaceutical preparation containing oxycodone and naloxone |
EP2422773A3 (en) * | 2002-09-20 | 2012-04-18 | Alpharma, Inc. | Sequestering subunit and related compositions and methods |
US20060003004A1 (en) * | 2002-10-25 | 2006-01-05 | Collegium Pharmaceutical, Inc. | Pulsatile release compositions of milnacipran |
US20040121010A1 (en) * | 2002-10-25 | 2004-06-24 | Collegium Pharmaceutical, Inc. | Pulsatile release compositions of milnacipran |
WO2004067039A1 (en) * | 2003-01-28 | 2004-08-12 | Collegium Pharmaceutical, Inc. | Multiparticulate compositions of milnacipran for oral administration |
US20040202717A1 (en) * | 2003-04-08 | 2004-10-14 | Mehta Atul M. | Abuse-resistant oral dosage forms and method of use thereof |
TWI347201B (en) | 2003-04-21 | 2011-08-21 | Euro Celtique Sa | Pharmaceutical products,uses thereof and methods for preparing the same |
EP1604666A1 (en) * | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD) |
DK1811957T3 (da) * | 2004-10-19 | 2009-03-30 | Krka Tovarna Zdravil D D Novo | Fast farmaceutisk sammensætning omfattende donepezilhydrochlorid |
EP1702558A1 (en) * | 2005-02-28 | 2006-09-20 | Euro-Celtique S.A. | Method and device for the assessment of bowel function |
UA91376C2 (ru) * | 2005-08-24 | 2010-07-26 | Рубикон Рисеч Пвт Лтд. | Рецептура с контролируемым высвобождением |
PT2719378T (pt) * | 2006-06-19 | 2016-11-02 | Alpharma Pharmaceuticals Llc | Composições farmacêuticas |
WO2008042279A2 (en) * | 2006-09-29 | 2008-04-10 | The Procter & Gamble Company | Oral compositions containing gel networks |
US8623418B2 (en) * | 2007-12-17 | 2014-01-07 | Alpharma Pharmaceuticals Llc | Pharmaceutical composition |
US20100151014A1 (en) * | 2008-12-16 | 2010-06-17 | Alpharma Pharmaceuticals, Llc | Pharmaceutical composition |
WO2009088673A2 (en) * | 2007-12-17 | 2009-07-16 | Alpharma Pharmaceuticals, Llc | Pharmaceutical composition |
JP5406288B2 (ja) * | 2008-07-07 | 2014-02-05 | ユーロ−セルティーク エス.エイ. | 尿閉を治療するためのオピオイド拮抗薬の使用 |
KR20140141727A (ko) | 2009-03-10 | 2014-12-10 | 유로-셀티큐 에스.에이. | 옥시코돈 및 날록손을 포함하는 즉시 방출 제약 조성물 |
JP2016525138A (ja) | 2013-07-23 | 2016-08-22 | ユーロ−セルティーク エス.エイ. | 疼痛および腸内ディスバイオシスをもたらす疾患および/または腸内細菌移行に対するリスクを高める疾患に罹患している患者における痛みの治療への使用のためのオキシコドンおよびナロキソンの組み合わせ |
CN114053235B (zh) * | 2020-08-07 | 2023-07-18 | 广州白云山光华制药股份有限公司 | 茶碱缓释片及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3965256A (en) * | 1972-05-16 | 1976-06-22 | Synergistics | Slow release pharmaceutical compositions |
US4443428A (en) | 1982-06-21 | 1984-04-17 | Euroceltique, S.A. | Extended action controlled release compositions |
FR2535202B1 (fr) * | 1982-11-03 | 1985-08-09 | Fabre Sa Pierre | Comprimes de theophylline a liberation controlee et leur procede de fabrication |
US4743247A (en) * | 1984-08-13 | 1988-05-10 | Alza Corporation | Process for manufacturing dosage form |
US4753800A (en) * | 1985-10-04 | 1988-06-28 | Warner-Lambert Company | Medicament adsorbates and their preparation |
US4892742A (en) * | 1985-11-18 | 1990-01-09 | Hoffmann-La Roche Inc. | Controlled release compositions with zero order release |
GB8613688D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
ES2058111T3 (es) * | 1986-06-10 | 1994-11-01 | Euro Celtique Sa | Composicion de liberacion controlada de dihidrocodeina. |
GB8626098D0 (en) * | 1986-10-31 | 1986-12-03 | Euro Celtique Sa | Controlled release hydromorphone composition |
GB8628728D0 (en) * | 1986-12-02 | 1987-01-07 | Euro Celtique Sa | Spheroids |
-
1988
- 1988-06-02 GB GB888813064A patent/GB8813064D0/en active Pending
-
1989
- 1989-05-19 GB GB8911629A patent/GB2219207B/en not_active Expired - Fee Related
- 1989-05-23 DE DE8989305209T patent/DE68904119T2/de not_active Expired - Lifetime
- 1989-05-23 AT AT89305209T patent/ATE83925T1/de not_active IP Right Cessation
- 1989-05-23 ES ES89305209T patent/ES2053989T3/es not_active Expired - Lifetime
- 1989-05-23 EP EP89305209A patent/EP0344960B1/en not_active Expired - Lifetime
- 1989-05-24 AU AU35127/89A patent/AU610401B2/en not_active Expired
- 1989-05-29 CA CA000600949A patent/CA1323834C/en not_active Expired - Lifetime
- 1989-05-30 IL IL90462A patent/IL90462A/xx unknown
- 1989-05-31 NZ NZ229372A patent/NZ229372A/en unknown
- 1989-06-01 JP JP1140229A patent/JPH0816060B2/ja not_active Expired - Lifetime
- 1989-06-01 DK DK198902668A patent/DK175130B1/da not_active IP Right Cessation
- 1989-06-01 NO NO892229A patent/NO176232C/no not_active IP Right Cessation
- 1989-06-01 PT PT90722A patent/PT90722B/pt not_active IP Right Cessation
- 1989-06-01 FI FI892664A patent/FI93695C/fi active IP Right Grant
- 1989-06-01 KR KR1019890007506A patent/KR0136279B1/ko not_active IP Right Cessation
- 1989-06-02 ZA ZA894201A patent/ZA894201B/xx unknown
- 1989-06-12 IE IE174489A patent/IE61998B1/en not_active IP Right Cessation
-
1991
- 1991-05-17 US US07/704,714 patent/US5091189A/en not_active Expired - Lifetime
-
1993
- 1993-02-17 GR GR930400321T patent/GR3007088T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2219207B (en) | 3-alkylxanthine containing controlled release dosage forms having a defined water content | |
IL83363A (en) | Use of indol-3-yl-carboxylic acid endo-8-methyl-8-aza- bicyclo (3,2,1) oct-3-yl ester for the preparation of psycho-active pharmaceutical compositions suitable for the treatment of stress- related psychiatric disorders or for increasing vigilance | |
GB8825024D0 (en) | Drug carrier | |
EP0295903A3 (en) | Hair preparation | |
GR3004208T3 (da) | ||
FR2640505B1 (fr) | Preparation pour l'apport de fer, preparation pour l'apport de vitamines et procede pour stabiliser une preparation effervescente | |
DE3379268D1 (en) | 1'-(3-(1,2-benzisoxazol-3-yl)propyl)spiro-(benzofuran-2-(3h),3' or 4'-piperidine or 3'-pyrrolidines), a process for their preparation and their use as medicaments | |
IT1215332B (it) | Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica | |
ZA885372B (en) | Nutrieut mixture intended for the elderly | |
GR3007347T3 (da) | ||
EP0334097A3 (en) | Process for the preparation of 4,4'-dihalogeno-bisphenyls | |
FR2518881B1 (fr) | Medicaments a base de 26,23-lactones de la 25-hydroxyvitamine d3, utiles notamment pour agir sur la concentration en calcium du serum | |
EP0269452A3 (en) | Use of ketone derivatives for the manufacture of medicaments | |
HUT53610A (en) | Herbicides containing derivatives of 5-(3,4,5,6-tetrahydroftalamid)-cinnamon acid and process for production of the active substances | |
IT8882523A0 (it) | Metodo per l'avanzamento del piede particolarmente nei pedali per velocipedi. | |
PT88680A (pt) | Dispositif de controle d'etancheite d'un recipient pour confinement d'un fluide sous pression | |
Kuczmann | Behaviour of PVC Powder Grains Produced Using Suspension Technology, in Processing | |
Mahamwal | Regulation of foreign investment in India | |
EP0337789A3 (en) | Apparatus for oral administration of a medicament | |
Haines | Hypnotherapeutic reductions of dental patient's distress | |
Carruthers | More to Mitchell; the elusive art of WO Mitchell's Jake and the Kid. | |
FRANCIS | THE MYTH OF" ZINC-FREE" BRONZES | |
AU2590688A (en) | Child's chair with safety device | |
CS440287A1 (en) | Device for level height's automatic regulation in crystallizer | |
AU7089687A (en) | Child's small bed which can be transformed into an adult's bed |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed |